A detailed history of Fermata Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Fermata Advisors, LLC holds 4,753 shares of JNJ stock, worth $744,937. This represents 0.16% of its overall portfolio holdings.

Number of Shares
4,753
Previous 5,132 7.39%
Holding current value
$744,937
Previous $750,000 2.67%
% of portfolio
0.16%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$145.48 - $167.38 $55,136 - $63,437
-379 Reduced 7.39%
4,753 $770,000
Q2 2024

Jul 12, 2024

SELL
$144.38 - $157.78 $4,042 - $4,417
-28 Reduced 0.54%
5,132 $750,000
Q1 2024

Apr 12, 2024

SELL
$155.22 - $162.74 $173,846 - $182,268
-1,120 Reduced 17.83%
5,160 $816,000
Q4 2023

Jan 19, 2024

SELL
$145.6 - $158.88 $105,560 - $115,188
-725 Reduced 10.35%
6,280 $984,000
Q3 2023

Nov 06, 2023

BUY
$155.75 - $174.48 $873,601 - $978,658
5,609 Added 401.79%
7,005 $1.09 Million
Q2 2023

Jul 24, 2023

SELL
$154.35 - $166.11 $462,895 - $498,163
-2,999 Reduced 68.24%
1,396 $231,000
Q1 2023

Apr 12, 2023

SELL
$151.05 - $180.26 $217,209 - $259,213
-1,438 Reduced 24.65%
4,395 $681,000
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $70,488 - $79,107
-440 Reduced 7.01%
5,833 $1.03 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $39,687 - $44,161
-246 Reduced 3.77%
6,273 $1.03 Million
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $636,935 - $704,419
3,787 Added 138.62%
6,519 $1.16 Million
Q1 2022

Apr 22, 2022

SELL
$158.14 - $179.59 $90,614 - $102,905
-573 Reduced 17.34%
2,732 $484,000
Q4 2021

Feb 02, 2022

SELL
$155.93 - $173.01 $2,806 - $3,114
-18 Reduced 0.54%
3,305 $565,000
Q3 2021

Oct 29, 2021

BUY
$161.5 - $179.47 $9,851 - $10,947
61 Added 1.87%
3,323 $537,000
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $136,674 - $146,606
857 Added 35.63%
3,262 $538,000
Q1 2021

May 18, 2021

BUY
$153.07 - $170.48 $368,133 - $410,004
2,405 New
2,405 $397,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fermata Advisors, LLC Portfolio

Follow Fermata Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fermata Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fermata Advisors, LLC with notifications on news.